AxoGen, Inc.
AXGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $818,946 | $494,819 | $836,274 | $739,573 |
| - Cash | $23,902 | $26,036 | $18,096 | $27,554 |
| + Debt | $19,752 | $68,188 | $68,443 | $68,686 |
| Enterprise Value | $814,796 | $536,971 | $886,621 | $780,705 |
| Revenue | $60,082 | $56,662 | $48,560 | $49,405 |
| % Growth | 6% | 16.7% | -1.7% | – |
| Gross Profit | $45,993 | $42,018 | $34,933 | $37,575 |
| % Margin | 76.6% | 74.2% | 71.9% | 76.1% |
| EBITDA | $12,649 | $4,376 | $298 | $4,165 |
| % Margin | 21.1% | 7.7% | 0.6% | 8.4% |
| Net Income | $708 | $579 | -$3,834 | $450 |
| % Margin | 1.2% | 1% | -7.9% | 0.9% |
| EPS Diluted | 0.013 | 0.012 | -0.085 | 0.009 |
| % Growth | 5% | 114.3% | -1,002.1% | – |
| Operating Cash Flow | $3,223 | $7,730 | -$13,179 | $8,735 |
| Capital Expenditures | -$1,865 | -$722 | -$256 | -$813 |
| Free Cash Flow | $1,358 | $7,008 | -$13,435 | $7,922 |